Member Info for Pebble101

Louis, he is still shown as CEO on the investors page.

Laticfnatic, many many years ago my husband spent a weekend rebadging and reboxing fax machines. They were not allowed to tell anyone about it so I am not surprised it hasn't been confirmed and likely won't be.

That's true but I'm not aware of anything legal to stop another company buying - whether or not they want to is another question.

I agree with Kaeren. Also I wouldn't think there is anything to stop a company buying Novacyt but I suspect any offer would be very low to take in worse case scenario with the dispute. Due diligence brings out anything of which the purchasing company should be made aware but they would have to be living under a rock to not know about the dispute.

JM is only acting CEO which suggests that they are looking for someone else to fulfill the role. I wonder why he wasn't offered the job. How much authority will he have to push the button on M.A?

The stand looked like it had been set up by a teenager on work experience. Appalling. I've said before you can't believe there is a marketing man in charge.

Handy111 has suggested what I was about to say, I had Private Eye in mind.

21ATS, I was just about to write the same.

Novacyt will just claim NDA. I think they need to respond that it has been CTDA accredited and people should be able to draw their own conclusions from that.

Have had a chance to listen now. Clonit - should this have been an RNS or Reach?

ValJu, one of the questions I asked was how they were going to attract II's because if they want to reduces the PI's they will need to do this. I haven't had chance to look at the presentation yet but I doubt they gave an answer to this. I also wanted to know if there was any revision to their proposed £100m turnover in the next five years give the constant downward estimates to date.

I have sent some questions in, three I think have a chance of being answered or skirted around, the other three I think will be ignored. I hadn't thought of asking them if that was an option :)

I must admit I'm worried about tomorrow, gone are the heady days when an RNS was exciting. I'm confused as to why a marketing person is so reticent about announcing anything positive. I'm holding as SP has gone down so far I might as well, coupled with the fact when I sell the shares normally rally.

Biosynex has signed an agreement to acquire 100% of the capital of the Italian company Bigix Pharma from its founding partners.

B2HS2L That was going to be one of my questions. I am tempted to ask if they think JW and DA provide shareholders value for money.

CS, wouldn't the DHSC have revealed any damning data by now? I am assuming anything like that would have already been produced in previous negotiations.

This might be of interest : https://www.icaew.com/technical/audit-and-assurance/professional-scepticism/coronavirus-considering-going-concern/how-to-report-on-material-uncertainty-related-to-going-concern-a-guide-for-auditors#:~:text=The%20auditor%20should%20give%20a,cast%20significant%20doubt%20on%20the

HarChris, the auditors have concluded that the use of the going concern basis of accounting is appropriate therefore I can't see why it would change what the company is allowed to do. Miffed about the £11m LTIP payment due in 2022 giving the uncertainty. I would like to know if that could be recovered IF anything was written off as a result of the court case.

If I hadn't already invested so much I would be at these levels.

My concern is that with Oxford Nanopore and Abingdon, the DHSC didn't actually start legal proceedings and settlements were agreed. Someone who has seen the contracts must have advised the DHSC they had grounds to take NCYT to court despite all the evidence people have found suggesting Novacyt should win the case.